FDA Inspection 988732 — Avista Pharma Solutions, Inc.

Avista Pharma Solutions, Inc. — FEI 1220785

The FDA completed an inspection of Avista Pharma Solutions, Inc. on June 15, 2016 in Agawam, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 15, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Agawam, MA (United States)